Pharmaceutical
Indications

 




Leading Researchers:

Hemostatic Soft Tissue Adhesives

Novel bio-adhesives based on the natural polymers, gelatin (protein) and alginate (polysaccharide), and a carbodiimide crosslinking agent. The carbodiimide crosslinking agent is much less toxic than other crosslinking agents used in bioadhesives and Read More >

Leading Researchers:

BiPS for the treatment of Diabetes

Additional information can be provided upon request. Read More >

Leading Researchers:

Implantation of pancreatic islet into the paranasal sinuses as a noninvasive cell therapy for diabetes

The long-term goal of the proposed project is to create a noninvasive or minimaly invasive technology for cell therapy of diabetes. Such technology will be used for conduction of clinical trials with pancreatic islets implantation in paranasal sinuse Read More >

Leading Researchers:

Omentum based scaffold for tissue engineering

Hydrogels for treating heart diseases: Injectable hydrogels have been developed as potential translatable materials to impact the cascade of events that occur after MI. These hydrogels, consisting of either synthetic or natural materials, form throug Read More >

Leading Researchers:

Biomarkers for risk assessment in colorectal cancer patients

TechnologyWe have developed an ELISA-based immunoassay that measures the levels of two proteins in the blood, Mortalin/GRP75 and HSP70, identifying colorectal cancer patients at high risk of poor survival.Mortalin/GRP75, is a ubiquitous mitochondrial Read More >

Leading Researchers:

REGULATION OF AMYLOID BETA MOLECULAR COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE

THE NEED Currently available treatment options for AD are symptomatic and do not modify the progression of the disease. This disease-modifying technology achieves previously unattainable blockage of cognitive deterioration in AD. The technology rever Read More >

Leading Researchers:

Enzyme replacement therapy for lysosomal storage diseases

Lysosomal Storage diseases (LSD) are inherited genetic defects, resulting in an enzyme deficiency. This deficiency prevents the lysosome from metabolizing cellular waste, and results in their accumulation in the cell. Excessive storage of proteins, Read More >

Leading Researchers:

Compositions for treating ophthalmic medical conditions

Additional information can be provided upon request. Read More >

Leading Researchers:

miRNA for the treatment of Melanoma

Additional information can be provided upon request. Read More >

Leading Researchers:

Multifunctional 5-aminolevulinic acid prodrugs activating 5 diverse cell-death pathways

The present invention provides drug conjugates comprising 5-aminolevulinic acid (ALA), an aldehyde and a carboxylic acid that may function as a histone deacetylase inhibitor (HDACI). These conjugates may serve as co-drugs which release a plurality of Read More >